Aller au contenu principal
Profil bibliographique

Eric P. Anderson

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

21Publications signalées
302Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Clostridium difficile and Clostridium perfringens researchOdor and Emission Control TechnologiesTraumatic Ocular and Foreign Body InjuriesAsthma and respiratory diseasesToxic Organic Pollutants Impact

Les publications récentes

Accès ouvert 2025 article OpenAlex

Exposure–Response Relationships in Patients with Non‐Small‐Cell Lung Cancer and Other Solid Tumors Treated with Patritumab Deruxtecan (HER3‐DXd)

Li Li, Mark Andrew Lee, Rujuta H. Joshi, Yuan Xu et autres

Patritumab deruxtecan (HER3-DXd, also known as MK-1022), an antibody-drug conjugate consisting of a human epidermal growth factor receptor 3 (HER3) antibody attached to a topoisomerase I inhibitor payload (DXd), has demonstrated efficacy in patients with metastatic breast cancer and non-small cell lung …

us (code pays fourni par la source)

1 citation Clinical Pharmacology & Therapeutics
Accès ouvert 2023 article OpenAlex

gPKPDviz : A flexible R shiny tool for pharmacokinetic/pharmacodynamic simulations using mrgsolve

Tong Lu, Victor Poon, Logan Brooks, Erick F. Velasquez et autres

GPKPDviz is a Shiny application (app) dedicated to real-time simulation, visualization, and assessment of the pharmacokinetic/pharmacodynamic (PK/PD) models. Within the app, gPKPDviz is capable of generating virtual populations and complex dosing and sampling scenarios, which, together with the streamlined workflow, is designed …

us (code pays fourni par la source)

5 citations CPT Pharmacometrics & Systems Pharmacology
Accès ouvert 2023 article OpenAlex

Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma

Rui Zhu, Xiaoning Wang, Eric P. Anderson, Michelle Deng et autres

Omalizumab is the first approved anti-immunoglobulin E (IgE) agent for the treatment of moderate to severe persistent inadequately controlled allergic asthma in adults and adolescents (≥ 12 years old). In 2016, it was approved in pediatric patients (6-11 years old). The objective …

us (code pays fourni par la source)

2 citations The AAPS Journal
2019 article OpenAlex

Whole transcriptome analysis of smoker palatal mucosa identifies multiple downregulated innate immunity genes

Yun Wang, Eric P. Anderson, Dimitris N. Tatakis

BACKGROUND: Smoking has significant negative impact on periodontal health and treatment outcomes. The molecular effects of smoking on oral immune homeostasis have not been fully elucidated. The present study aimed to provide a comprehensive assessment of smoking-associated gene expression changes in healthy …

us (code pays fourni par la source)

16 citations Journal of Periodontology
Accès ouvert 2019 article OpenAlex

Serial Changes in Pulmonary Function Testing in A Patient with Tracheobronchial Amyloidosis: Relevance for Early Diagnosis

Cecilia L. Benz, Marcus Geffre, Eric P. Anderson, Kara J. Johnson et autres

Amyloidosis is a disease of abnormal extracellular deposition of proteins within tissues, commonly affecting solid organs such as the heart, liver, and kidneys. Less commonly, amyloidosis may affect the proximal tracheobronchial tree. Clinical symptoms are vague and may include shortness of breath, …

0 citations Journal of Integrative Cardiology Open Access
2019 article OpenAlex

Corneal Foreign Body

Anthony J. Camodeca, Eric P. Anderson

Corneal foreign bodies account for the second most common form of ocular trauma, with corneal abrasions being number one. In general, major morbidity such as visual acuity loss is not common. Many corneal foreign bodies are superficial, and benign, albeit uncomfortable.

us (code pays fourni par la source)

1 citation StatPearls
2017 article OpenAlex

Safety Performance of Flashing Yellow Arrow for Protected–Permissive Left-Turn Signal Control in Central Illinois

Kerrie L. Schattler, Eric P. Anderson, Trevor R. Hanson

In 2010, the Illinois Department of Transportation began implementing the flashing yellow arrow (FYA) at intersections operating with protected–permissive left-turn (PPLT) control. Research was conducted to evaluate the safety-effectiveness of FYAs at 86 intersections and 164 approaches in central Illinois. The effectiveness …

us (code pays fourni par la source)

5 citations Transportation Research Record Journal of the Transportation Research Board

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.